Cannabidiol Drugs Clinical Trial Outcomes and Adverse Effects

Volume: 11
Published: Feb 25, 2020
Abstract
This review aims to present completed clinical trial data surrounding the medicinal benefits and potential side effects of the increasingly popular cannabidiol (CBD)-based drug products, specifically Epidiolex. The article is divided into two sections based on if the ailment being treated by this cannabinoid is classified as either physiological or neurological conditions. In addition to describing the current status, we also examined the...
Paper Details
Title
Cannabidiol Drugs Clinical Trial Outcomes and Adverse Effects
Published Date
Feb 25, 2020
Volume
11
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.